P. Wulandari Harahap, S. Putra Tarigan, and N. Novisari Soeroso, “Adverse Event Of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment In Medan Among Pulmonary Adenocarcinoma: Focus On Non-Hematologic Toxicity”, IJHP, vol. 5, no. 3, pp. 422–429, Aug. 2025.